<qa>  What is the name of the group that received placebo during Phase I?This phase will last 4 weeks. Subjects that received placebo during Phase I and continue to present aggressive behaviors will receive risperidone on an open basis. All visits, dosing, and assessment instruments will be the same as in Phase I. This represents an opportunity to identify all potential responders to risperidone as an augmenting agent. 